RP Bio Inc. (KOSDAQ:314140)

South Korea flag South Korea · Delayed Price · Currency is KRW
6,250.00
+70.00 (1.13%)
At close: Apr 29, 2026
14.89%
Market Cap 54.16B
Revenue (ttm) 136.22B
Net Income (ttm) 4.68B
Shares Out 8.67M
EPS (ttm) 541.00
PE Ratio 11.55
Forward PE n/a
Dividend 50.00 (0.79%)
Ex-Dividend Date Dec 29, 2025
Volume 11,069
Average Volume 13,754
Open 6,220.00
Previous Close 6,180.00
Day's Range 6,110.00 - 6,250.00
52-Week Range 5,350.00 - 9,130.00
Beta 0.59
RSI 47.90
Earnings Date n/a

About RP Bio

RP Bio Inc., a bio-health company, engages in the research, development, manufacture, and sale of soft capsules in Korea and internationally. It offers animal, vegetable, antihistamine, and chewable soft capsules; hard capsules; and jelly and powder sticks; Urusa, flagship soft capsule; omega-3 and lutein products, and granule, effervescent granule, and stick type capsule powders. The company also provides cold and liver medicines; vitamins; blood circulation improvers; and pain relievers. The company was founded in 1983 and is headquartered in... [Read more]

Industry Pharmaceutical Preparations
Founded 1983
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 314140
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.